Charleston Hand Therapy Center - Medicare Occupational Therapist in Charleston, SC

Charleston Hand Therapy Center is a medicare enrolled "Occupational Therapist - Hand" provider in Charleston, South Carolina. Their current practice location is 1483 Tobias Gadson Blvd, Suite 205b, Charleston, South Carolina. You can reach out to their office (for appointments etc.) via phone at (843) 766-7694.

Charleston Hand Therapy Center is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Charleston Hand Therapy Center is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1124462148.

Contact Information

Charleston Hand Therapy Center
1483 Tobias Gadson Blvd, Suite 205b,
Charleston, SC 29407-8702
(843) 766-7694
(843) 766-6495



Healthcare Provider's Profile

Full NameCharleston Hand Therapy Center
TypeFacility
SpecialityOccupational Therapist - Hand
Location1483 Tobias Gadson Blvd, Charleston, South Carolina
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1124462148
  • Provider Enumeration Date: 04/21/2013
  • Last Update Date: 06/28/2013
  Medicare PECOS Information:
  • PECOS PAC ID: 5193964419
  • Enrollment ID: O20130618000478

Medical Identifiers

Medical identifiers for Charleston Hand Therapy Center such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1124462148NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225XH1200XOccupational Therapist - Hand (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Charleston Hand Therapy Center acts as a billing entity for following providers:
Provider NameElizabeth F De Herder
Provider TypePractitioner - Occupational Therapist In Private Practice
Provider IdentifiersNPI Number: 1891743514
PECOS PAC ID: 9133153125
Enrollment ID: I20111216000260

News Archive

Biovator and BASF sign collaboration agreement to develop In Vitro test systems

The Sweden-based biotech company Biovator and the global chemical industry leader BASF have signed a collaboration agreement for final development of In Vitro test systems capable of identifying the potential of chemical compounds to induce allergic reaction in humans. The agreement also includes a five-year BASF option of final product deliveries.

Longer looks: Parents' crusade on rare diseases; fighting obesity; experts' view of alternative medicine

In the beginning, Chris Hempel noticed the clumsiness. Her girls tripped over toys on the floor. Their grandfather said he couldn't teach them to pedal their tricycles. … The Hempels learned of people who called themselves citizen-scientists. Many shared research papers and their day-to-day experience. Some talked of their willingness to try any promising drug. Others sought a role as equal partners with researchers. Scientists, while sympathetic, generally believe their work should be left to experts. Families are encouraged to raise money if they want to help, but the traditional view is that amateurs can't shape research or find cures. The Hempels found a maddening gap between the search for scientific knowledge and the search for treatments (Amy Docker Marcus, 11/2013).

Co-occurring contaminants in groundwater may heighten health risks for North Carolinians

Contaminants that occur together naturally in groundwater under certain geological conditions may heighten health risks for millions of North Carolinians whose drinking water comes from private wells, and current safety regulations don't address the problem, a new Duke University study finds.

Arno Therapeutics announces dosing of first patient in Phase II clinical study of AR-67

Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced the dosing of the first patient in a Phase II clinical study of its third-generation camptothecin compound, AR-67, in patients with Glioblastoma Multiforme (GBM), an aggressive form of brain cancer.

Home health care nursing lowers hospitalizations and transfers to nursing homes

In the largest study of its kind, a University of Pennsylvania School of Nursing investigation shows that home health agencies providing organizational support to their nurses get better outcomes.

Read more Medical News

› Verified 5 days ago

Provider NameLaura A Cramer
Provider TypePractitioner - Occupational Therapist In Private Practice
Provider IdentifiersNPI Number: 1760851273
PECOS PAC ID: 8022328517
Enrollment ID: I20151112003009

News Archive

Biovator and BASF sign collaboration agreement to develop In Vitro test systems

The Sweden-based biotech company Biovator and the global chemical industry leader BASF have signed a collaboration agreement for final development of In Vitro test systems capable of identifying the potential of chemical compounds to induce allergic reaction in humans. The agreement also includes a five-year BASF option of final product deliveries.

Longer looks: Parents' crusade on rare diseases; fighting obesity; experts' view of alternative medicine

In the beginning, Chris Hempel noticed the clumsiness. Her girls tripped over toys on the floor. Their grandfather said he couldn't teach them to pedal their tricycles. … The Hempels learned of people who called themselves citizen-scientists. Many shared research papers and their day-to-day experience. Some talked of their willingness to try any promising drug. Others sought a role as equal partners with researchers. Scientists, while sympathetic, generally believe their work should be left to experts. Families are encouraged to raise money if they want to help, but the traditional view is that amateurs can't shape research or find cures. The Hempels found a maddening gap between the search for scientific knowledge and the search for treatments (Amy Docker Marcus, 11/2013).

Co-occurring contaminants in groundwater may heighten health risks for North Carolinians

Contaminants that occur together naturally in groundwater under certain geological conditions may heighten health risks for millions of North Carolinians whose drinking water comes from private wells, and current safety regulations don't address the problem, a new Duke University study finds.

Arno Therapeutics announces dosing of first patient in Phase II clinical study of AR-67

Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced the dosing of the first patient in a Phase II clinical study of its third-generation camptothecin compound, AR-67, in patients with Glioblastoma Multiforme (GBM), an aggressive form of brain cancer.

Home health care nursing lowers hospitalizations and transfers to nursing homes

In the largest study of its kind, a University of Pennsylvania School of Nursing investigation shows that home health agencies providing organizational support to their nurses get better outcomes.

Read more Medical News

› Verified 5 days ago

Provider NameJoshua D Morrisette
Provider TypePractitioner - Occupational Therapist In Private Practice
Provider IdentifiersNPI Number: 1982147997
PECOS PAC ID: 1951686161
Enrollment ID: I20170329002521

News Archive

Biovator and BASF sign collaboration agreement to develop In Vitro test systems

The Sweden-based biotech company Biovator and the global chemical industry leader BASF have signed a collaboration agreement for final development of In Vitro test systems capable of identifying the potential of chemical compounds to induce allergic reaction in humans. The agreement also includes a five-year BASF option of final product deliveries.

Longer looks: Parents' crusade on rare diseases; fighting obesity; experts' view of alternative medicine

In the beginning, Chris Hempel noticed the clumsiness. Her girls tripped over toys on the floor. Their grandfather said he couldn't teach them to pedal their tricycles. … The Hempels learned of people who called themselves citizen-scientists. Many shared research papers and their day-to-day experience. Some talked of their willingness to try any promising drug. Others sought a role as equal partners with researchers. Scientists, while sympathetic, generally believe their work should be left to experts. Families are encouraged to raise money if they want to help, but the traditional view is that amateurs can't shape research or find cures. The Hempels found a maddening gap between the search for scientific knowledge and the search for treatments (Amy Docker Marcus, 11/2013).

Co-occurring contaminants in groundwater may heighten health risks for North Carolinians

Contaminants that occur together naturally in groundwater under certain geological conditions may heighten health risks for millions of North Carolinians whose drinking water comes from private wells, and current safety regulations don't address the problem, a new Duke University study finds.

Arno Therapeutics announces dosing of first patient in Phase II clinical study of AR-67

Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced the dosing of the first patient in a Phase II clinical study of its third-generation camptothecin compound, AR-67, in patients with Glioblastoma Multiforme (GBM), an aggressive form of brain cancer.

Home health care nursing lowers hospitalizations and transfers to nursing homes

In the largest study of its kind, a University of Pennsylvania School of Nursing investigation shows that home health agencies providing organizational support to their nurses get better outcomes.

Read more Medical News

› Verified 5 days ago

Provider NameJoseph A Costner
Provider TypePractitioner - Occupational Therapist In Private Practice
Provider IdentifiersNPI Number: 1487120705
PECOS PAC ID: 9830438092
Enrollment ID: I20190305002789

News Archive

Biovator and BASF sign collaboration agreement to develop In Vitro test systems

The Sweden-based biotech company Biovator and the global chemical industry leader BASF have signed a collaboration agreement for final development of In Vitro test systems capable of identifying the potential of chemical compounds to induce allergic reaction in humans. The agreement also includes a five-year BASF option of final product deliveries.

Longer looks: Parents' crusade on rare diseases; fighting obesity; experts' view of alternative medicine

In the beginning, Chris Hempel noticed the clumsiness. Her girls tripped over toys on the floor. Their grandfather said he couldn't teach them to pedal their tricycles. … The Hempels learned of people who called themselves citizen-scientists. Many shared research papers and their day-to-day experience. Some talked of their willingness to try any promising drug. Others sought a role as equal partners with researchers. Scientists, while sympathetic, generally believe their work should be left to experts. Families are encouraged to raise money if they want to help, but the traditional view is that amateurs can't shape research or find cures. The Hempels found a maddening gap between the search for scientific knowledge and the search for treatments (Amy Docker Marcus, 11/2013).

Co-occurring contaminants in groundwater may heighten health risks for North Carolinians

Contaminants that occur together naturally in groundwater under certain geological conditions may heighten health risks for millions of North Carolinians whose drinking water comes from private wells, and current safety regulations don't address the problem, a new Duke University study finds.

Arno Therapeutics announces dosing of first patient in Phase II clinical study of AR-67

Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced the dosing of the first patient in a Phase II clinical study of its third-generation camptothecin compound, AR-67, in patients with Glioblastoma Multiforme (GBM), an aggressive form of brain cancer.

Home health care nursing lowers hospitalizations and transfers to nursing homes

In the largest study of its kind, a University of Pennsylvania School of Nursing investigation shows that home health agencies providing organizational support to their nurses get better outcomes.

Read more Medical News

› Verified 5 days ago

Provider NameKelley Marie Martin
Provider TypePractitioner - Occupational Therapist In Private Practice
Provider IdentifiersNPI Number: 1528739612
PECOS PAC ID: 9931576642
Enrollment ID: I20221109003431

News Archive

Biovator and BASF sign collaboration agreement to develop In Vitro test systems

The Sweden-based biotech company Biovator and the global chemical industry leader BASF have signed a collaboration agreement for final development of In Vitro test systems capable of identifying the potential of chemical compounds to induce allergic reaction in humans. The agreement also includes a five-year BASF option of final product deliveries.

Longer looks: Parents' crusade on rare diseases; fighting obesity; experts' view of alternative medicine

In the beginning, Chris Hempel noticed the clumsiness. Her girls tripped over toys on the floor. Their grandfather said he couldn't teach them to pedal their tricycles. … The Hempels learned of people who called themselves citizen-scientists. Many shared research papers and their day-to-day experience. Some talked of their willingness to try any promising drug. Others sought a role as equal partners with researchers. Scientists, while sympathetic, generally believe their work should be left to experts. Families are encouraged to raise money if they want to help, but the traditional view is that amateurs can't shape research or find cures. The Hempels found a maddening gap between the search for scientific knowledge and the search for treatments (Amy Docker Marcus, 11/2013).

Co-occurring contaminants in groundwater may heighten health risks for North Carolinians

Contaminants that occur together naturally in groundwater under certain geological conditions may heighten health risks for millions of North Carolinians whose drinking water comes from private wells, and current safety regulations don't address the problem, a new Duke University study finds.

Arno Therapeutics announces dosing of first patient in Phase II clinical study of AR-67

Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced the dosing of the first patient in a Phase II clinical study of its third-generation camptothecin compound, AR-67, in patients with Glioblastoma Multiforme (GBM), an aggressive form of brain cancer.

Home health care nursing lowers hospitalizations and transfers to nursing homes

In the largest study of its kind, a University of Pennsylvania School of Nursing investigation shows that home health agencies providing organizational support to their nurses get better outcomes.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Charleston Hand Therapy Center is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Charleston Hand Therapy Center
1483 Tobias Gadson Blvd, Suite 205b,
Charleston, SC 29407-8702

Ph: (843) 856-3200
Charleston Hand Therapy Center
1483 Tobias Gadson Blvd, Suite 205b,
Charleston, SC 29407-8702

Ph: (843) 766-7694

News Archive

Biovator and BASF sign collaboration agreement to develop In Vitro test systems

The Sweden-based biotech company Biovator and the global chemical industry leader BASF have signed a collaboration agreement for final development of In Vitro test systems capable of identifying the potential of chemical compounds to induce allergic reaction in humans. The agreement also includes a five-year BASF option of final product deliveries.

Longer looks: Parents' crusade on rare diseases; fighting obesity; experts' view of alternative medicine

In the beginning, Chris Hempel noticed the clumsiness. Her girls tripped over toys on the floor. Their grandfather said he couldn't teach them to pedal their tricycles. … The Hempels learned of people who called themselves citizen-scientists. Many shared research papers and their day-to-day experience. Some talked of their willingness to try any promising drug. Others sought a role as equal partners with researchers. Scientists, while sympathetic, generally believe their work should be left to experts. Families are encouraged to raise money if they want to help, but the traditional view is that amateurs can't shape research or find cures. The Hempels found a maddening gap between the search for scientific knowledge and the search for treatments (Amy Docker Marcus, 11/2013).

Co-occurring contaminants in groundwater may heighten health risks for North Carolinians

Contaminants that occur together naturally in groundwater under certain geological conditions may heighten health risks for millions of North Carolinians whose drinking water comes from private wells, and current safety regulations don't address the problem, a new Duke University study finds.

Arno Therapeutics announces dosing of first patient in Phase II clinical study of AR-67

Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced the dosing of the first patient in a Phase II clinical study of its third-generation camptothecin compound, AR-67, in patients with Glioblastoma Multiforme (GBM), an aggressive form of brain cancer.

Home health care nursing lowers hospitalizations and transfers to nursing homes

In the largest study of its kind, a University of Pennsylvania School of Nursing investigation shows that home health agencies providing organizational support to their nurses get better outcomes.

Read more News

› Verified 5 days ago


Occupational Therapist in Charleston, SC

Mr. Shawn Styles, OTR
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 1941 Savage Road, Suite 400c, Charleston, SC 29407
Phone: 843-571-2700    Fax: 843-571-2124
Mira Kraft, OTR/L
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 2230 Ashley Crossing Dr, Charleston, SC 29414
Phone: 843-766-5228    
Mrs. Alysson Miller Goodwin, OTR/L
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 29 Race St, Charleston, SC 29403
Phone: 318-792-1696    
Amanda Prester Beacham, OTR/L
Occupational Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 45 Sycamore Ave Apt 917, Charleston, SC 29407
Phone: 843-900-6202    Fax: 843-574-8858
Mary Katherine Melroy, O.T.R.
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 236 Confederate Cir, Charleston, SC 29407
Phone: 843-718-5898    
Amanda Zoccolo,
Occupational Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 637 Highwood Cir, Charleston, SC 29412
Phone: 678-516-2709    
Julia Gilkerson, OTR/L
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 34 Colleton Dr, Charleston, SC 29407
Phone: 843-991-7709    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.